Tuesday, May 5, 2015
- 4:48pm-5:00pm
-
Interim Safety Experience in Transplant Patients Treated With Belatacept (Nulojix) in the Post-Approval Setting
Concurrent Session: Kidney Complications: Other • Room 118-AB
- 4:48pm-5:00pm
-
Quality of Life, Financial, and Mental Health Outcomes for Individuals Turned Down for Live Kidney Donation
Concurrent Session: Kidney: Living Donor Issues III • Terrace I-III
- 5:00pm-5:12pm
-
Adherence Time-Profiles of Renal Transplant Patients During the Three First Years Post-Transplantation
- 5:00pm-5:12pm
-
Adverse Events of Maintenance Immunosuppression Following Kidney Transplantation Reported in Randomized Controlled Trials: A Systematic Review
Concurrent Session: Kidney Complications: Other • Room 118-AB
- 5:00pm-5:12pm
-
Biomarkers of Deceased Donors for the Prediction of Renal Allograft Outcomes
Concurrent Session: Kidney: Risk Prediction • Room 120-ABC
- 5:00pm-5:12pm
-
Extended Life-Supporting Xenogeneic Lung Function With Multi-Transgeneic Donor Pigs and Targeted Drug Treatments
- «Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 47
- Next Page»